27.80
price down icon2.04%   -0.58
after-market Dopo l'orario di chiusura: 27.80
loading
Precedente Chiudi:
$28.38
Aprire:
$28.29
Volume 24 ore:
5.15M
Relative Volume:
1.05
Capitalizzazione di mercato:
$14.26B
Reddito:
$17.28B
Utile/perdita netta:
$108.00M
Rapporto P/E:
139.00
EPS:
0.2
Flusso di cassa netto:
$391.00M
1 W Prestazione:
-0.61%
1M Prestazione:
-19.63%
6M Prestazione:
-24.15%
1 anno Prestazione:
-30.57%
Intervallo 1D:
Value
$27.52
$28.50
Intervallo di 1 settimana:
Value
$26.25
$30.82
Portata 52W:
Value
$26.25
$41.18

Baxter International Inc Stock (BAX) Company Profile

Name
Nome
Baxter International Inc
Name
Telefono
(847) 948-2000
Name
Indirizzo
ONE BAXTER PKWY, DEERFIELD, IL
Name
Dipendente
60,000
Name
Cinguettio
@baxter_intl
Name
Prossima data di guadagno
2024-11-08
Name
Ultimi documenti SEC
Name
BAX's Discussions on Twitter

Confronta BAX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Instruments & Supplies icon
BAX
Baxter International Inc
27.80 14.26B 17.28B 108.00M 391.00M 0.20
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
488.27 174.93B 8.35B 2.32B 1.30B 6.41
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
202.04 58.01B 20.64B 1.73B 2.94B 6.02
Medical Instruments & Supplies icon
ALC
Alcon Inc
91.42 45.22B 9.91B 1.02B 665.00M 2.05
Medical Instruments & Supplies icon
RMD
Resmed Inc
213.97 31.43B 4.93B 1.25B 1.38B 8.47
Medical Instruments & Supplies icon
COO
The Cooper Companies, Inc.
77.80 15.49B 3.90B 392.30M 288.10M 1.95

Baxter International Inc Stock (BAX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-26 Ripresa Goldman Buy
2025-02-24 Aggiornamento Argus Hold → Buy
2025-02-20 Ripresa Barclays Overweight
2024-07-15 Downgrade Morgan Stanley Equal-Weight → Underweight
2024-05-30 Iniziato Goldman Neutral
2024-05-10 Downgrade TD Cowen Buy → Hold
2023-05-30 Ripresa Morgan Stanley Equal-Weight
2023-03-29 Iniziato UBS Neutral
2023-01-06 Downgrade Morgan Stanley Overweight → Equal-Weight
2023-01-05 Downgrade Raymond James Outperform → Mkt Perform
2023-01-03 Downgrade BofA Securities Buy → Neutral
2022-12-19 Downgrade JP Morgan Overweight → Neutral
2022-12-15 Downgrade Deutsche Bank Buy → Hold
2022-12-12 Downgrade Citigroup Buy → Neutral
2022-10-18 Iniziato Barclays Overweight
2022-10-12 Iniziato Jefferies Hold
2022-06-24 Downgrade Wells Fargo Overweight → Equal Weight
2022-04-04 Downgrade Goldman Neutral → Sell
2022-03-02 Ripresa BofA Securities Buy
2022-02-18 Reiterato KeyBanc Capital Markets Overweight
2022-02-18 Reiterato Morgan Stanley Overweight
2022-02-18 Reiterato Raymond James Outperform
2022-02-18 Reiterato Stifel Buy
2022-02-18 Reiterato UBS Neutral
2022-02-18 Reiterato Wells Fargo Overweight
2022-02-11 Iniziato Goldman Neutral
2022-01-07 Ripresa Citigroup Buy
2022-01-07 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2021-09-13 Aggiornamento Cowen Market Perform → Outperform
2021-09-03 Aggiornamento Barclays Equal Weight → Overweight
2021-05-25 Iniziato Barclays Equal Weight
2021-01-29 Downgrade Piper Sandler Overweight → Neutral
2021-01-06 Downgrade UBS Buy → Neutral
2020-12-15 Downgrade Goldman Buy → Neutral
2020-10-01 Aggiornamento Citigroup Neutral → Buy
2020-09-04 Downgrade Argus Buy → Hold
2020-06-24 Iniziato Oppenheimer Outperform
2020-03-19 Aggiornamento Stifel Hold → Buy
2020-03-18 Aggiornamento KeyBanc Capital Markets Sector Weight → Overweight
2020-03-05 Iniziato Citigroup Neutral
2020-02-13 Iniziato Goldman Buy
2020-01-02 Aggiornamento Evercore ISI In-line → Outperform
2019-12-17 Downgrade Morgan Stanley Overweight → Equal-Weight
2019-06-26 Iniziato KeyBanc Capital Markets Sector Weight
2019-04-08 Downgrade Evercore ISI Outperform → In-line
2019-01-02 Aggiornamento Citigroup Neutral → Buy
2019-01-02 Aggiornamento Morgan Stanley Underweight → Overweight
2018-11-02 Aggiornamento Argus Hold → Buy
2018-10-16 Iniziato Barclays Underweight
2018-05-17 Ripresa Piper Jaffray Overweight
2018-02-06 Reiterato Citigroup Neutral
2018-01-03 Iniziato Evercore ISI Outperform
2018-01-03 Aggiornamento Raymond James Mkt Perform → Outperform
Mostra tutto

Baxter International Inc Borsa (BAX) Ultime notizie

pulisher
04:43 AM

Baxter to Host First-Quarter 2025 Financial Results Conference C - GuruFocus

04:43 AM
pulisher
04:17 AM

Baxter to Host First-Quarter 2025 Financial Results Conference Call for Investors - The Joplin Globe

04:17 AM
pulisher
08:30 AM

Latest Trends in Adhesion Barrier Market: 2024 to 2031 | Baxter - openPR.com

08:30 AM
pulisher
Apr 14, 2025

LSV Asset Management Has $159.96 Million Stake in Baxter International Inc. (NYSE:BAX) - MarketBeat

Apr 14, 2025
pulisher
Apr 14, 2025

Baxter International (NYSE:BAX) Reaches New 1-Year LowShould You Sell? - MarketBeat

Apr 14, 2025
pulisher
Apr 14, 2025

BAX Stock Declines Despite Latest Product Launch Boosting Patient Care - TradingView

Apr 14, 2025
pulisher
Apr 13, 2025

Jaffetilchin Investment Partners LLC Has $1.92 Million Stock Holdings in Baxter International Inc. (NYSE:BAX) - MarketBeat

Apr 13, 2025
pulisher
Apr 13, 2025

Baxter International (BAX) Q3 2024 Earnings Call Transcript - Fortune

Apr 13, 2025
pulisher
Apr 12, 2025

Baxter International (NYSE:BAX) Sets New 12-Month LowHere's Why - MarketBeat

Apr 12, 2025
pulisher
Apr 11, 2025

Baxter International Inc. (NYSE:BAX) Position Raised by Russell Investments Group Ltd. - MarketBeat

Apr 11, 2025
pulisher
Apr 11, 2025

Baxter International Enters Oversold Territory (BAX) - Nasdaq

Apr 11, 2025
pulisher
Apr 11, 2025

Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery - PharmiWeb.com

Apr 11, 2025
pulisher
Apr 11, 2025

Baxter Launches New Room Temperature Hemopatch Sealing Hemostat - GuruFocus

Apr 11, 2025
pulisher
Apr 11, 2025

Hurricane Helene impact on Baxter to further limit IV fluid supply, HHS says - AOL.com

Apr 11, 2025
pulisher
Apr 10, 2025

Cullen Capital Management LLC Decreases Holdings in Baxter International Inc. (NYSE:BAX) - MarketBeat

Apr 10, 2025
pulisher
Apr 10, 2025

Global Prefilled Syringes Market to Cross USD 28 Billion by 2032 | DelveInsight - GlobeNewswire Inc.

Apr 10, 2025
pulisher
Apr 10, 2025

Breakthrough: Baxter's Enhanced Hemopatch Eliminates Surgery Prep Time with Room-Temperature Storage - Stock Titan

Apr 10, 2025
pulisher
Apr 10, 2025

Geode Capital Management LLC Buys 290,279 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat

Apr 10, 2025
pulisher
Apr 09, 2025

Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch

Apr 09, 2025
pulisher
Apr 09, 2025

Wound Care Market to Witness Remarkable Growth with 3M, Baxter, - openPR.com

Apr 09, 2025
pulisher
Apr 08, 2025

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Baxter International Inc.(BAX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

Apr 08, 2025
pulisher
Apr 08, 2025

Artificial Kidney Market to See Revolutionary Growth | Baxter - openPR.com

Apr 08, 2025
pulisher
Apr 07, 2025

Baxter International Inc (BAX) Shares Down 3.27% on Apr 7 - GuruFocus

Apr 07, 2025
pulisher
Apr 07, 2025

Citigroup Adjusts Baxter International Price Target to $35 From $37, Maintains Neutral Rating - MarketScreener

Apr 07, 2025
pulisher
Apr 07, 2025

Baxter stock touches 52-week low at $28.22 amid market challenges - Investing.com Australia

Apr 07, 2025
pulisher
Apr 07, 2025

Baxter stock touches 52-week low at $28.22 amid market challenges By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

Intravenous Solutions Market Is Booming Worldwide | Baxter - openPR.com

Apr 07, 2025
pulisher
Apr 07, 2025

Allstate Corp Makes New $450,000 Investment in Baxter International Inc. (NYSE:BAX) - MarketBeat

Apr 07, 2025
pulisher
Apr 05, 2025

Baxter International (NYSE:BAX) CEO Change as Stock Dips 2% Last Quarter - Yahoo Finance

Apr 05, 2025
pulisher
Apr 04, 2025

Baxter International Inc. (NYSE:BAX) Short Interest Update - MarketBeat

Apr 04, 2025
pulisher
Apr 03, 2025

Healthcare: Policy Uncertainty Is Countered by Interest in Defensive Stocks - Morningstar

Apr 03, 2025
pulisher
Apr 03, 2025

US hospitals strained by IV fluid supply limits after Helene hit production site - AOL.com

Apr 03, 2025
pulisher
Apr 02, 2025

Evercore ISI Adjusts Baxter International Price Target to $45 From $44, Maintains Outperform Rating - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

Baxter International Inc. (NYSE:BAX) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Apr 02, 2025
pulisher
Apr 01, 2025

Baxter CEO pay surged before his departure — along with the median employee’s wage - Medical Design & Outsourcing

Apr 01, 2025
pulisher
Apr 01, 2025

Is Baxter International Inc. (BAX) the Most Undervalued Healthcare Stock to Buy According to Analysts? - Insider Monkey

Apr 01, 2025
pulisher
Apr 01, 2025

Baxter International (NYSE:BAX) investors are sitting on a loss of 55% if they invested five years ago - simplywall.st

Apr 01, 2025

Baxter International Inc Azioni (BAX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
medical_instruments_supplies WST
$212.50
price down icon 0.08%
$57.86
price down icon 1.67%
medical_instruments_supplies COO
$77.80
price down icon 1.22%
$164.15
price down icon 0.89%
$65.93
price down icon 2.76%
Capitalizzazione:     |  Volume (24 ore):